Radioligands for the study of brain 5-HT(1A) receptors in vivo- development of some new analogues of WAY

Nuclear Medicine and Biology

Volumn 27, Issue 5, 2000, Pages 449-455

  Pike, Victor W ^a   Halldin, Christer ^b   Wikström, Håkan ^c   Marchais, Sandrine ^c   McCarron, Julie A ^a   Sandell, Johan ^b   Nowicki, Bartek ^c   Swahn, Carl Gunnar ^b   Osman, Safiye ^a   Hume, Susan P ^a   Constantinou, Maria ^a   Andrée, Bengt ^b   Farde, Lars ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

5 HT(1A) receptors; Brain; Carbon 11; Fluorine 18; PET; Radioligands; WAY

Indexed keywords

CARBON 11; FLUORINE 18; IODINE 123; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RADIOISOTOPE; RADIOLIGAND; SEROTONIN 1A RECEPTOR;

BRAIN TOMOGRAPHY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DRUG METABOLISM; HALOGENATION; HUMAN; ISOTOPE LABELING; LIGAND BINDING; LIPOPHILICITY; PLASMA CLEARANCE; RECEPTOR AFFINITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION;

EID: 18744428452     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00110-4     Document Type: Article

References (46)

1. Artigas F., Pere V. and Alvarez E. (1994) Pindolol induces a rapid improvement of patients with depression treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51, 248-251.
2. Baumgarten H. G. and Göthert M., Eds. (1997) Serotoninergic Neurons and 5-HT Receptors in the CNS. Handbook of Experimental Pharmacology. Springer-Verlag, Berlin.
3. Blier P., Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15:1995;217-222.
4. 1A antagonists. WO95/33743; PCT/GB95/01263.
5. Budinger T.F. PET instrumentation What are the limits? Sem. Nucl. Med. 28:1998;247-267.
6. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia . Neurochem. Int. 30:1997;565-574.
7. 1A antagonist WAY-100635 for PET. J. Nucl. Med. 39, 135P (Abstract 553).
8. 1A receptors in vivo and gives a more intense signal than WAY. J. Labelled Compd. Radiopharm. 42(suppl 1), S63-S65.
9. Farde L., Ito H., Swahn C.-G., Pike V.W., Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. J. Nucl. Med. 39:1998;1965-1971.
10. Goldberg H.L., Finnerty R.J. The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiatry. 136:1979;1184-1187.
11. 11C]WAY-100635 for PET. Neuroimage. 8:1998;426-440.
12. 11C]WAY-100635. Brain Res. 745:1997;96-108.
13. 1A receptors in vivo. Eur J. Nucl. Med. 26, 991 (Abstract OS 120).
14. 1A receptors. In: Serotoninergic Neurons and 5-HT Receptors in the CNS (Baumgarten H. G. and Göthert M., Eds.). Handbook of Experimental Pharmacology, pp. 239-268. Springer-Verlag, Berlin.
15. 1A receptors in prefrontal and temporal cortices of brains with chronic schizophrenia. Life Sci. 48:1991;355-363.
16. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., Grasby P.M. Evidence for striatal dopamine release during a video game. Nature. 393:1998;266-268.
17. 123I]p-MPPI in nonhuman primates. Synapse. 24:1996;273-281.
18. 1A receptors in rat brain. Synapse. 18:1994;359-366.
19. 1A receptor. J. Nucl. Med. 40, 37P (Abstract 149).
20. Lang L., Jagoda E., Sassaman M. B., Magata Y. and Eckelman W. C. (1999) Comparison of F-18 labeled cis and trans 4-fluorocyclohexane derivatives of WAY 100635. J. Nucl. Med. 40, 37P (Abstract 150).
21. 1A silent antagonists. J. Nucl. Med. 39, 36P (Abstract 132).
22. 1A antagonists. J. Med. Chem. 42:1999;1576-1586.
23. 18F]MPPF, a fluoro analog of WAY-100635. Nucl. Med. Biol. 25:1998;342-350.
24. 1A receptor ligand, WAY-100635. Submitted to Biorg. Med. Chem.
25. 1A receptor studies. J. Labelled Compd. Radiopharm. 37, 292-294 (Abstract).
26. 1A receptors with positron emission tomography . Life Sci. 55:1994;L403-PL407.
27. 1A binding-sites in frontal cortex of suicide victims. J. Neural Transmissions. 85:1991;181-194.
28. 11C-carboxylation of an immobilised Grignard reagent. J. Labelled Compd. Radiopharm. 38:1996;941-953.
29. 11C]methanesulphonates. J. Labelled Compd. Radiopharm. 42:(suppl 1):1999;S132-S135.
30. Morris E.D., Fisher R.E., Alpert N.M., Rauch S.L., Fischman A.J. In vivo imaging of neuromodulation using positron emission tomography; optimal ligand characteristics and task length for detection of activation. Human Brain Mapping. 3:1995;35-55.
31. 11C]WAY-1000635 - Explanation of high signal contrast in PET and an aid to biomathematical modelling. Nucl. Med. Biol. 25:1998;215-223.
32. 11C]WAY-1000635, in monkey and human plasma by HPLC Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET . Nucl. Med. Biol. 23:1996;627-634.
33. 1A receptors in vitro and in vivo. Eur. J. Nucl. Med. 25, 338-346.
34. 11C]WAY-100635. Med. Chem. Res. 5:1995;208-227.
35. 11C]WAY-100635. Eur. J. Pharmacol. 283:1995;R1-R3.
36. 11C]WAY-100635. Eur. J. Pharmacol. 301:1996;R5-R7.
37. 2A receptors. J. Nucl. Med. 55, 20P (Abstract).
38. 1A receptor in humans . Synapse. 25:1997;147-154.
39. 1A receptor ligand for PET studies. J. Nucl. Med. 35, 252P (Abstract).
40. Thielen R.J., Fangon N.B., Frazer A. 4-(2′-Methoxyphenyl)-1-[2′-[N-(2′′pyridinyl)-p- iodobenzamido]ethyl]piperazine and 4-(2′-methoxyphenyl)-1-[2′-[N-(2′′-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors. J. Pharmacol. Exp. Ther. 277:1996;661-670.
41. 11C]raclopride in the human brain. Synapse. 16:1994;255-262.
42. 1A antagonist WAY-100635; radiosynthesis and in vivo evaluation. Nucl. Med. Biol. 23:1996;487-490.
43. 1A receptors. J. Labelled Compd. Radiopharm. 42:1999;611-620.
44. 1A ligands . J. Med. Chem. 37:1994;4572-4575.
45. 1A receptors . J. Labelled Compd. Radiopharm. 37:1995;297-298.
46. 1A ligand . J. Med. Chem. 37:1994;1406-1407.